These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 1479686
1. [Bacteriological evaluation of ofloxacin otic solution]. Deguchi K, Yokota N, Koguchi M, Suzuki Y, Suzuki K, Fukayama S, Ishihara R, Oda S. Jpn J Antibiot; 1992 Oct; 45(10):1342-55. PubMed ID: 1479686 [Abstract] [Full Text] [Related]
2. [A clinical bacteriological efficacy study on a fosfomycin otic solution]. Deguchi K, Yokota N, Tanaka S, Fukayama S, Nishimura Y, Yoshihara H, Oda S, Matsumoto Y, Ikegami R, Sato K. Jpn J Antibiot; 1986 Sep; 39(9):2344-54. PubMed ID: 3099028 [Abstract] [Full Text] [Related]
3. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution]. Deguchi K, Fukayama S, Nishimura Y, Nishike A, Oda S, Sato S, Matsumoto Y, Ikegami R, Yokota N, Tanaka S. Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166 [Abstract] [Full Text] [Related]
4. [Antimicrobial activity of ofloxacin against recent clinical isolates from otitis media and otitis externa]. Matsumoto Y, Suzuki Y, Ishii Y, Ishihara R, Nakazawa A, Nakane Y, Nishinari C, Deguchi K. Jpn J Antibiot; 1998 Sep; 51(9):561-75. PubMed ID: 9846283 [Abstract] [Full Text] [Related]
6. [Antibacterial activities of ofloxacin against recent clinical isolates from patients with ocular infections]. Deguchi K, Yokota N, Koguchi M, Suzuki Y, Suzuki K, Fukayama S, Ishihara R, Oda S. Jpn J Antibiot; 1993 May; 46(5):349-63. PubMed ID: 8326675 [Abstract] [Full Text] [Related]
7. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections]. Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R, Oda S. Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856 [Abstract] [Full Text] [Related]
10. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution]. Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H. Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757 [Abstract] [Full Text] [Related]
11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution]. Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H. Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754 [Abstract] [Full Text] [Related]
12. Ofloxacin otic solution: a review of its use in the management of ear infections. Simpson KL, Markham A. Drugs; 1999 Sep; 58(3):509-31. PubMed ID: 10493278 [Abstract] [Full Text] [Related]
14. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution]. Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H. Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333 [Abstract] [Full Text] [Related]
15. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents. Klein JO. Pediatr Infect Dis J; 2001 Jan; 20(1):102-3; discussion 120-2. PubMed ID: 11176586 [Abstract] [Full Text] [Related]
18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). I. Susceptibility distribution]. Kosakai N, Kumamoto Y, Sakai S, Hirose T, Okayama S, Shigeta S, Shiraiwa Y, Yoshida H, Miura Y, Ogata M. Jpn J Antibiot; 1987 Dec; 40(12):1975-2011. PubMed ID: 3448255 [Abstract] [Full Text] [Related]